Navigation Links
Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
Date:5/20/2008

Data on Newly-Approved Cimzia(R) Presented at Digestive Disease Week (DDW)

SAN DIEGO, May 20 /PRNewswire/ -- UCB announced today that data presented at Digestive Disease Week reaffirm the long-term, sustainable efficacy and safety of Cimzia(R) (certolizumab pegol) at stable doses in treating patients with moderate to severe Crohn's disease. Data also showed continued remission amongst the majority of responders and the remission rate remained stable in many of the patients who were re-induced with Cimzia(R). These results represent data from the PRECiSE trial program, which evaluated more than 1,300 patients receiving continuous treatment with Cimzia(R) (400 mg) for up to 18 months.

"The long-term Cimzia(R) data provide very important information for clinical practitioners treating people with Crohn's disease," said study investigator Gary R. Lichtenstein, M.D., professor of medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa. "In clinical trials, Cimzia(R) showed remarkable and sustainable long-term results without the need for dose escalation. Further, patients can achieve long-term symptom relief and remission regardless of the magnitude and rapidity of onset of the initial response."

Cimzia(R) is the first and only PEGylated anti-TNF (Tumor Necrosis Factor alpha) antibody approved for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy. Cimzia(R) was approved by the U.S. Food and Drug Administration (FDA) on April 22, 2008.

UCB, the manufacturer of Cimzia(R), presented analyses of the PRECiSE 3 and 4 open-label extension studies, which demonstrated the long-term efficacy of Cimzia(R) in treating Crohn's disease. PRECiSE 3 data showed that eight out of ten patients who were in remission at six months stayed in remission for up to 18 months. Furthermore, 35 percent of pat
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
2. Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
3. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
4. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
5. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
6. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
7. Gene Therapy Provides Vision to People who Were Nearly Blind
8. Arpida Provides Further Comments on the Pivotal Phase III Trials
9. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
10. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Vivex Biomedical, Inc., a leading processor of human ... today that it hired Lou Barnes as ... Vivex Biomedical formed UMTB Biomedical as a wholly-owned subsidiary ... in November 2014. UMTB is the oldest tissue bank ... twenty-five year veteran of the tissue banking industry, having ...
(Date:3/2/2015)... -- Akron Children,s Hospital has been designated a Diagnostic Imaging ... Radiology (ACR), making it the first hospital in ... in the United States to ... the ACR as a DICOE provides validation that our ... national benchmarks," says Dr. Michael Rubin , chairman, ...
(Date:3/2/2015)... 2, 2015  Kush Bottles, North ... solutions for the marijuana industry, announced today that ... been nominated for a 2015 Excellence in Entrepreneurship ... Award is designed to recognize individuals who exemplify ... their creativity and determination, have established and nurtured ...
Breaking Medicine Technology:Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2
(Date:3/2/2015)... Wants and Needs ” was featured on NewsWatch as ... and coolest mobile applications on the iOS, Android, and ... host of NewsWatch, conducted the app review and shared ... , Whether a person needs help re-orienting or prioritizing ... allows people to enter and track wants, both good ...
(Date:3/2/2015)... 2015 Doctors in Novara, Italy have ... predictor of outcomes for people with mesothelioma than other ... of the new study on the Surviving Mesothelioma website. ... of Eastern Piedmont followed the cases of 172 ... excess lung fluid. , “Persistent lung expansion after ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction , ... Week (March 1-7, sponsored by the National Association of ... Month, Robins & Morton is recognizing several women whose ... construction industry as a whole. From the craft professionals, ... in between, each woman has a story to share. ...
(Date:3/2/2015)... March 02, 2015 New York ... Unplugged™—will be delivering a plenary address entitled Finding ... the Art of Healing and Recovery at this ... Behavioral Healthcare Executive Summit (BHES).     , With more ... songs have been recorded by some of the ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Representatives ... it has officially launched a multivitamin supplement that’s ... of product development for BNatrl, said the multivitamin, ... from Olympic and other world-class athletes. , "Being ... use this pure whole food multivitamin to improve ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... FindingsBAYSIDE, N.Y., May 28 Once every five ... and medical experts on Tourette Syndrome (TS) -- ... and sounds -- convene to disseminate and share ... condition.As part of its basic mission to identify ...
... than 20 pounds , , THURSDAY, May 28 (HealthDay News) ... pregnancy to between 11 and 20 pounds to safeguard ... newly updated expert guidelines. , That level of gestational ... pregnant women and reflects the concern over the rising ...
... Associate Professor and Director of Biomaterials Research at ... Dentistry, has been awarded a grant in the ... the National Institutes of Health to develop new ... composites, bonding agents, and sealants. Currently most dental ...
... TRAVERSE CITY, Mich., May 28 Versus Technology, Inc. ("Versus" or ... for its second fiscal quarter ended April 30, 2009, a ... quarter of the prior year. Revenues for the six ... for the six months ended April 30, 2008, a 3.5% ...
... Inc. (Nasdaq: STRM ) today announced ... Company,s document workflow solutions will be integrated into ... within an additional leading Canadian healthcare region. Integrating ... view into a patient,s complete history of care ...
... 28 Aventis Pharmaceutical Inc., a wholly owned subsidiary of ... $95.5 million to settle allegations that it violated the False ... its Medicaid Drug Rebate obligations, the Justice Department announced today. ... The settlement resolves allegations that between 1995 ...
Cached Medicine News:Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 2Health News:5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment 3Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 2Health News:Experts Urge Less Weight Gain for Obese Women in Pregnancy 3Health News:Versus Technology Announces Second Quarter Results 2Health News:Versus Technology Announces Second Quarter Results 3Health News:Versus Technology Announces Second Quarter Results 4Health News:Versus Technology Announces Second Quarter Results 5Health News:Versus Technology Announces Second Quarter Results 6Health News:Versus Technology Announces Second Quarter Results 7Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 2Health News:Streamline Health Document Workflow Solution to be Integrated Into Electronic Medical Records System for Leading Canadian Healthcare Region 3Health News:Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: